LDN Social Media
Get connected with us on social networks
Sarah Zielsdorf, MD, MS - Beyond Tired: CFS/ME or Not? (2017 Conference) (LDN, low dose naltrexone)
Dr Zielsdorf shares case studies of patients with CFS and ME and goes into the evidence showing that the hallmark of CFS/ME is a mitochondrial dysfunction and intense diet, nutritional antioxidant and other lifestyle modifications are the primary therapy for this disorder.
Low Dose Naltrexone (LDN) is an important adjunct to all of Dr Zielsdorf’s patients after remarkably thorough testing and lifestyle changes to get to the bottom of patients' ailments. Low Dose Naltrexone (LDN) as an adjunct therapy has served very well and has had several great successes.
Further conference presentations can be found https://ldnresearchtrust.org/ldn-conferences